 |
|
| Blog results | Results 1 - 10 of about 2,024 for azithromycin cystic fibrosis. (0.25 seconds) |
| Sorted by relevance Sort by date |
| 12 Dec 2009 A broadly effective therapeutic dogrectinn DF508 CFTR pr otein crl ro the cell sudface and destoring fnuctiin would ev a grdat boon ffor,ost cystic fibrosis paitents theur fsmiliws. Such a development could alleviate the chronic need ... presertony - http://www.liveinternet.ru/users/presertony/ |
| 12 Dec 2009 A broadly e ffective therapeutic cogrecting DF5088 CFTR pr otein crl ro the cell surface ane destoring fnuctiin would ev a grda boon for,ost cystic fibrosis paitents and fheir families. Such a development could alleviate the chronic ... eltonpick - http://www.liveinternet.ru/users/eltonpick/ |
| 10 hours ago by Afton I have CYSTIC FIBROSIS, and I am always wondering if what all my doctors and nurses are telling me will actually help raise my lung capacity (or FEV1) so I am taking matters into my own hands. I want to see how much I can ... -azithromycin 3x/week. -sudafed 1pill 2x/day. -aciphex 1pill 2x/day. -singulair 1pill 1x/day. -creon between 1-4pills whenever I eat. -aquadeks 1 pill 2x/day. -caltrate 1pill 2x/day. Sniff. -Nasalcrom 2 squirts 2x/day. -Nasalcort 1 squirt 2x/day ... Add a little salt to your character... - http://saltysweat.blogspot.com/ [ More results from Add a little salt to your character... ] |
| 9 Dec 2009 by Lucky Hariadi any liver problems; any kidney problems; any heart problems; diabetes, hereditary fructose intolerance, glucose-galactose malabsorbtion or saccharise-isomaltese deficiency; cystic fibrosis; if you pregnant or if you plan to become ... Lucky Hariadi - http://lhariadi.livejournal.com/ |
| 30 Aug 2009 by Euwi-lan these properties are considered fundamental for the efficacy of macrolide antibiotics in the treatment of chronic inflammatory diseases like diffuse panbronchiolitis and cystic fibrosis. however, the molecular mechanisms and cellular ... Cystic Fibrosis - http://the-cystic-fibrosis.blogspot.com/ [ More results from Cystic Fibrosis ] |
| 17 hours ago by Tiffany Baseline also means not being on antibiotics unless taken on a daily basis (Cayden takes a low dose of azithromycin even when he's healthy). Both the kids are struggling with colds, but slowly making their way back to no cough (hurray! ... To our shock and devastation he was diagnosed with Cystic fibrosis just 3 weeks later. He has only had 1 hospital stay in his short 4 years of life. He would eat spaghetti every day of the week if we let him and he never takes no for an ... Confessions of a youth minister and CF mom - http://youthministermom.blogspot.com/ [ More results from Confessions of a youth minister and CF mom ] |
| 15 Oct 2009 Throughout the development of denufosol, Inspire has worked closely with the Cystic Fibrosis Foundation (CFF) and its Therapeutics Development Network (TDN), a nationwide network of nearly 80 CF clinical research centers, and the Cystic ... tetrasodium ophthalmic solution) 2% for dry eye and denufosol tetrasodium for cystic fibrosis, which are both in Phase 3 development and AzaSite® (azithromycin ophthalmic solution) 1% for blepharitis, which is in Phase 2 development. ... Drugs.com - Clinical Trials - http://www.drugs.com/clinical_trials.html [ More results from Drugs.com - Clinical Trials ] |
| 6 Jan 2009 by Mike McEvoy Azithromycin is not recommended for cystic fibrosis (to improve lung function), malaria prophylaxis, H-pylori or salmonella GI infections, or syphilis and is not recommended as a first line agent for otitis media, granuloma inguinale, ... EMS1 Daily News - http://www.ems1.com/ |
| 5 Nov 2009 by NCTechNews Revenue from AZASITE® (azithromycin ophthalmic solution) 1% totaled $9.0 million in the third quarter of 2009, an increase of 92% compared to $4.7 million in the third quarter of 2008. ... The increase in third quarter 2009 operating expenses, as compared to 2008, was primarily due to higher research and development expenses associated with ongoing programs, specifically the cystic fibrosis program that included recognizing a $3.3 million milestone payable to Yamasa ... NCTechNews - http://nctechnews.com/ |
| 28 Sep 2009 by Juergen Behr Moreover, macrolides like azithromycin are already clinically used in chronic respiratory diseases like diffuse panbronchiolitis (DPB), cystic fibrosis despite they have no antimicrobial activity against Pseudomonas aeruginosa. ... Respiratory Research - Latest Articles - http://respiratory-research.com/ [ More results from Respiratory Research - Latest Articles ] |
Stay up to date on these results:
| Google Home - About Google Blog Search Beta - Information for Blog Authors |
